highperformr logo

Palleon Pharmaceuticals's Overview

Total employees80
HeadquartersWaltham
Founded2015

Palleon Pharmaceuticals is a clinical-stage biotechnology company at the forefront of discovering and developing novel cancer immunotherapies. They are pioneering the field of glyco-immunology, focusing on the modulation of cell-surface glycans to overcome immunosuppression and unlock the body's anti-tumor immune response. Palleon's proprietary Sialoglycobiology Platform and EAGLE (Enzymatic Antibody Glycan Ligation) Platform enable the creation of first-in-class therapeutics, including enzyme-based candidates and glycan-specific ADCs, aimed at treating a wide range of cancers with significant unmet medical needs.

Where is Palleon Pharmaceuticals's Headquarters?

HQ Function

The headquarters serves as the primary center for Palleon's research and development, clinical operations, strategic partnerships, and corporate administration.

Notable Features:

The facility is equipped with state-of-the-art laboratories for drug discovery, biologic development, and translational research, alongside modern office and collaborative workspaces designed to foster scientific innovation.

Work Culture:

Palleon fosters a dynamic, science-driven work culture characterized by innovation, collaboration, and a strong commitment to scientific rigor and patient impact. Employees are typically mission-oriented, working towards breakthroughs in cancer therapy.

HQ Significance:

Its location in the Boston biotech hub provides Palleon with access to a rich talent pool, leading academic institutions, potential collaborators, and a supportive ecosystem for life science companies.

Values Reflected in HQ: The headquarters' design and functionality reflect Palleon's core values of scientific excellence, innovation, teamwork, and a dedication to addressing critical unmet needs in oncology.

Location:

While Palleon Pharmaceuticals is headquartered in the United States, its scientific research, collaborations, and clinical trial activities have a global reach. The company engages with international research institutions, contract research organizations (CROs), and clinical sites to advance its pipeline of glyco-immunology therapies for cancer patients worldwide. Their focus on novel biological pathways has relevance across the international scientific and medical communities.

Street Address:

200 West Street, Suite W310

City:

Waltham

State/Province:

Massachusetts

Country:

USA

Palleon Pharmaceuticals's Global Presence

Buying Intent Signals for Palleon Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Palleon Pharmaceuticals

As of April 2025, Palleon Pharmaceuticals' leadership includes:

Jim Broderick, M.D. - Chief Executive Officer
Li Peng, Ph.D. - Chief Scientific Officer
David Johnson, M.D. - Chief Medical Officer
Keri Monda, Ph.D. - Chief Business Officer
Nikolaos S. Tzanis, Ph.D. - Chief Development Officer
Greg Boucher - Chief Operating Officer

Investors of Palleon Pharmaceuticals

Palleon Pharmaceuticals has been backed by several prominent investors over the years, including:

SR One
Pfizer Ventures
MPM Capital
Matrix Capital Management
Vertex Ventures HC
Wellington Management
Logos Capital
Samsara BioCapital
Redmile Group

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits1

Over the past year, Palleon Pharmaceuticals experienced a significant change in its financial leadership with the departure of its Chief Financial Officer. The company currently does not list a CFO on its executive team page.

Departures

Nikolas Zorgias, Nikolas Zorgias departed from his role as Chief Financial Officer.

Technology (Tech Stack) used by Palleon Pharmaceuticals

Discover the tools Palleon Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Palleon Pharmaceuticals Email Formats and Examples

Palleon Pharmaceuticals commonly uses an email format that combines the first initial of an employee's first name with their full last name, followed by '@palleonpharma.com'. While other formats might exist within the organization, this is a frequently observed pattern.

[first_initial][last]@palleonpharma.com

Format

jbroderick@palleonpharma.com

Example

85%

Success rate

News and media

Business WireApril 9, 2024

Palleon Pharmaceuticals Presents Preclinical Data on Its EAGLE Platform and Novel Bi-Sialidase Constructs at the AACR Annual Meeting 2024

Palleon Pharmaceuticals shared new preclinical findings from its Enzymatic Antibody Glycan Ligation (EAGLE) platform and innovative bi-sialidase constructs during the American Association for Cancer Research (AACR) Annual Meeting 2024. The presented data underscored the potential of these strategies to boost anti-tumor immunity by modifying cell surface glycans....more

PR NewswireJanuary 4, 2024

Palleon Pharmaceuticals Doses First Patient in Phase 2 Clinical Trial of E-602 in Patients with Non-Small Cell Lung Cancer That Has Progressed on Anti-PD-1/PD-L1 Therapy

Palleon Pharmaceuticals announced that the first patient has been dosed in its Phase 2 clinical study of E-602. This investigational immunotherapy is being evaluated in patients with non-small cell lung cancer (NSCLC) whose disease advanced after treatment with anti-PD-1/PD-L1 therapy. E-602 is an engineered human sialidase aimed at desialylating tumors and immune cells to counteract glycan-mediated immune suppression....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Palleon Pharmaceuticals, are just a search away.